ResMed is leveraging smart devices and Big Data to strengthen its position in the global obstructive sleep apnea market by enabling physician monitoring of patient compliance, which enhances treatment adherence and supports reimbursement rates. The company also focuses on producing clinical data to highlight the health risks associated with untreated OSA and aims to promote broader diagnosis and treatment.
The content highlights ResMed's strategic focus on smart devices and Big Data to strengthen its position in the global obstructive sleep apnea market. For an investor, this indicates a potential growth opportunity as ResMed's technology enhances patient compliance, which could lead to higher reimbursement rates and increased demand for masks and accessories. This strategic approach may also drive wider diagnosis and treatment, potentially boosting long-term revenue streams.